CS logo
small CS logo
Kindai University Hospital; Neurology

Osaka, Japan
University hospital in Osakasayama
377-2 Onohigashi, Osakasayama, Osaka 589-8511

About Kindai University Hospital; Neurology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Kindai University Hospital; Neurology


During the past decade, Kindai University Hospital; Neurology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital; Neurology" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Kindai University Hospital; Neurology


According to Clinical.Site data, the most researched conditions in "Kindai University Hospital; Neurology" are "Bladder Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Generalized Myasthenia Gravis" (1 trials), "NMO Spectrum Disorder (NMOSD)" (1 trials) and "Neuromyelitis Optica (NMO)" (1 trials). Many other conditions were trialed in "Kindai University Hospital; Neurology" in a lesser frequency.

Clinical Trials Intervention Types at Kindai University Hospital; Neurology


Most popular intervention types in "Kindai University Hospital; Neurology" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Satralizumab" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "Baseline Treatment" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kindai University Hospital; Neurology


The vast majority of trials in "Kindai University Hospital; Neurology" are 4 trials for "All" genders.

Clinical Trials Status at Kindai University Hospital; Neurology


Currently, there are NaN active trials in "Kindai University Hospital; Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kindai University Hospital; Neurology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kindai University Hospital; Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".